ArticlebioRxiv : the preprint server for biology2022

An engineered ACE2 decoy receptor can be administered by inhalation and potently targets the BA.1 and BA.2 omicron variants of SARS-CoV-2.

Lianghui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.